维普中文期刊产品整合服务
32篇 您的检索式:作者名="TEBAS P"
    题名 作者 年代 出处 被引量
1Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy 显示文摘Wohl D A McComsey G Tebas P 2006Clinical Infectious Diseases2006,43,5:1
2Gene editing of CCR5in autologous CD4 T cells of persons infected with HIV显示文摘Tebas P Stein D Tang WW 2014N Engl J Med2014,370,10:1
3Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV 显示文摘Tebas P Stein D Tang WW 2014N Engl J Med2014,370,10:1
4Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infection显示文摘Tebas P Yarasheski K Henry K 2004AIDS Res Hum Retroviruses2004,20,:1
5Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infection显示文摘TEBAS P YARASHESKI K HENRY K 2004AIDS Res Hum Retroviruses2004,20,6:1
6Evaluation of the Virological and Metabolic Effects of Switching Protease Inhibitor Combination Antiretroviral Therapy to Nevirapine-based Therapy for the Treatment of HIV Infection显示文摘TEBAS P YARASHESKIK HENRY K 2004AIDS Res Hum Retroviruses2004,20,:1
7Insulin resistance in HIV protease inhibitor associated diabetes 显示文摘Yarasheki KE Tebas P Sigmund C 1999J Acquir Immune Deficysyndr1999,21,:1
8Accelerated bonemineral loss in HIV-infected patients receiving potentantiretroviral therapy 显示文摘Tebas P Powderly WG Claxton S 2000AIDS2000,14,4:1
9Metabolic and Immune Activation Effects of Treatment Interruption in Chronic HIV-1 Infection: Implications for Cardiovascular Risk显示文摘Tebas P Henry W K Matining R 2008Plos One2008,3,20:1
10Antiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long antisense to HIV显示文摘Tebas P Stein D Binder-Scholl G 2013{H}Blood2013,,09:1
11Metabolic and Immune Activation Effects of Treatment Interruption in Chronic HIV-1 Infection: Implications for Cardiovascular Risk 显示文摘Tebas P Henry WK Matining R 2008Plos one2008,3,20:1
12Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy显示文摘Tebas P Powderly WG Claxton S 2000AIDS2000,14,4:1
13Metabolic effects of darunavir/ritonavir versus atazanavir/ ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks显示文摘Aberg JA Tebas P Overton ET 2012AIDS Res Hum Retro- viruses2012,28,10:1
14Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV 显示文摘Tebas P Stein D Tang WW 2014N Engl J Med2014,370,10:1
15Gene editing of CCR5 in autologous CD4 T cells ofpersons infected with HIV 显示文摘Tebas P Stein D Tang WW Frank I Wang SQ Lee G Spratt SK Surosky RT Giedlin MA Nichol G HolmesMC Gregory PD Ando DG Kalos M Collman RG Binder-Scholl G Plesa G Hwang WT Levine BL JuneCH 2014N Engl J Med2014,370,10:1
16Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy显示文摘Tebas P Powderly WG Claxton S 2000AIDS2000,14,4:1
17Alendronatewith calcium and vitamin D supplementation is safeand effective for the treatment of decreased bone mineraldensity in HIV显示文摘MCCOMSEY G A KENDALL M A TEBAS P 2007AIDS2007,21,18:1
18Accelerated bone mineral loss in HIV-infected patiens receiving potent antiretroviral therapy显示文摘Tebas P Powderly WG Claxton S 0,,04:1
19Gene editing of CCR5 inautologous CD4 T cells of persons infected with HIV 显示文摘Tebas P Stein D Tang W W 2014N EnglJ Med2014,370,:1
20Gene editing of CCR5in autologous CD4 T cells of persons infected with HIV显示文摘Tebas P Stein D Tang WW 2014The New England journal of medicine2014,370,10:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费